SEC Form 4 · accession 0001209191-18-018862
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Vincent A. Miller
Officer — Chief Medical Officer
Period of report
Mar 9, 2018
Accepted (ET)
Mar 12, 2018 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 20, 2018 | M | 6,811 | $29.94 | A | 80,133 | D | |
| Common StockF1 | Feb 20, 2018 | S | 6,811 | $85.00 | D | 73,322 | D | |
| Common StockF1 | Feb 20, 2018 | S | 10,000 | $85.00 | D | 63,322 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $29.94 | Mar 9, 2018 | M | 6,811 | D | — | Apr 9, 2024 | Common Stock | 6,811 | 1,570 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
- F2The option was granted on April 9, 2014 and vests in equal quarterly installments beginning on June 30, 2014 until fully vested on March 31, 2018.